![Ann Thorell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ann Thorell
Direttore Finanziario/CFO presso
SERES THERAPEUTICS, INC.
Patrimonio netto: - $ in data 31/05/2026
Profilo
Ann Marella Thorell is currently Director at Living Beyond Breast Cancer, Director at ApcinteX Ltd. since 2021, and Chief Financial Officer & Executive Vice President at Seres Therapeutics, Inc. starting in 2024.
Former roles include Chairman at Vallon Pharmaceuticals, Inc. from 2022 to 2023; COO, CFO, Secretary & Executive Director at Realm Therapeutics Plc from 2014 to 2019; Director at Capella Bioscience Ltd. and Z Factor Ltd. from 2021 to 2022; Independent Director at ESSA Pharma, Inc. from 2019 to 2025 and at Carisma Therapeutics, Inc. from 2024 to 2025; CFO, Treasurer, SVP & Chief Accounting Officer at Evelo Biosciences, Inc. in 2023; President at Thorell Consulting; Chief Financial Officer at Palladio Biosciences, Inc. from 2019 to 2021; and Chief Accounting Officer at Centessa Pharmaceuticals Plc from 2021 to 2022.
Education includes undergraduate studies at Lehigh University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 13/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 31/05/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
Posizioni attive di Ann Thorell
| Società | Posizione | Inizio |
|---|---|---|
| SERES THERAPEUTICS, INC. | Direttore Finanziario/CFO | 25/03/2024 |
ApcinteX Ltd.
 ApcinteX Ltd. BiotechnologyHealth Technology Manufactures novel hemophilia drugs | Direttore/Membro del Consiglio | 29/01/2021 |
Living Beyond Breast Cancer
 Living Beyond Breast Cancer Living Beyond Breast Cancer is a company based in Haverford, PA. Jean A. Sachs has been the CEO of the company since 1996. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Ann Thorell
| Società | Posizione | Fine |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 31/12/2025 |
| ESSA PHARMA INC. | Direttore/Membro del Consiglio | 09/10/2025 |
| EVELO BIOSCIENCES, INC. | Direttore Finanziario/CFO | 20/11/2023 |
| GRI BIOPAR | Presidente | 21/04/2023 |
| CENTESSA PHARMACEUTICALS PLC | Comptroller/Controller/Auditor | 31/07/2022 |
Formazione di Ann Thorell
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
45
Relazioni di 1° grado
14
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
Realm Therapeutics Plc
 Realm Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops proprietary immunomodulatory products | Health Technology |
Lehigh University
 Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Living Beyond Breast Cancer
Living Beyond Breast Cancer Living Beyond Breast Cancer is a company based in Haverford, PA. Jean A. Sachs has been the CEO of the company since 1996. | |
ESSA Pharma, Inc.
 ESSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Health Technology |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
Evelo Biosciences, Inc.
 Evelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapeutics for small intestine related diseases | Health Technology |
Capella Bioscience Ltd.
 Capella Bioscience Ltd. Pharmaceuticals: MajorHealth Technology Develops novel medicines based on monoclonal antibodies to the next generation therapeutic targets in oncology and autoimmune disease | Health Technology |
Z Factor Ltd.
 Z Factor Ltd. BiotechnologyHealth Technology Engages in research and development of therapeutic agents to treat alpha-1 antitrypsin deficiency | Health Technology |
ApcinteX Ltd.
ApcinteX Ltd. BiotechnologyHealth Technology Manufactures novel hemophilia drugs | Health Technology |
Thorell Consulting
 Thorell Consulting Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Commercial Services |
Palladio Biosciences, Inc.
 Palladio Biosciences, Inc. BiotechnologyHealth Technology Develops transformative medicines for orphan diseases | Health Technology |
Vallon Pharmaceuticals, Inc.
 Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes proprietary biopharmaceutical products | Health Technology |
Centessa Pharmaceuticals Plc
 Centessa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that researches and develops medicines for neurological, neurodegenerative and neuropsychiatric disorders | Health Technology |
Carisma Therapeutics, Inc.
 Carisma Therapeutics, Inc. BiotechnologyHealth Technology Develops novel chimeric antigen receptor macrophage and CAR-monocyte technology treatment of non-muscle invasive bladder cancer | Health Technology |
